(Q40564751)

21 September 2017

title

Vpr-mediated incorporation of UNG2 into HIV-1 particles is required to modulate the virus mutation rate and for replication in macrophages (English)

1 reference

21 September 2017

Serge Benichou

5

0 references

author name string

Renxiang Chen

1

1 reference

21 September 2017

Erwann Le Rouzic

2

1 reference

21 September 2017

Jessica A Kearney

3

1 reference

21 September 2017

Louis M Mansky

4

1 reference

21 September 2017

language of work or name

English

0 references

publication date

19 April 2004

1 reference

Journal of Biological Chemistry

21 September 2017

published in

1 reference

21 September 2017

volume

279

1 reference

21 September 2017

issue

27

1 reference

21 September 2017

page(s)

28419-28425

1 reference

Docking of HIV-1 Vpr to the nuclear envelope is mediated by the interaction with the nucleoporin hCG1.

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

Incorporation of Vpr into human immunodeficiency virus type 1 requires a direct interaction with the p6 domain of the p55 gag precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 In vivo mutation rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

Influence of reverse transcriptase variants, drugs, and Vpr on human immunodeficiency virus type 1 mutant frequencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

Viral protein R regulates docking of the HIV-1 preintegration complex to the nuclear pore complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

Active nuclear import of human immunodeficiency virus type 1 preintegration complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

Roles of uracil-DNA glycosylase and dUTPase in virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

Genetic selection of peptide inhibitors of human immunodeficiency virus type 1 Vpr.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

Functional role of HIV-1 virion-associated uracil DNA glycosylase 2 in the correction of G:U mispairs to G:C pairs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

The mutation rate of human immunodeficiency virus type 1 is influenced by the vpr gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

Structure of the gene for human uracil-DNA glycosylase and analysis of the promoter function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

Inefficient excision of uracil from loop regions of DNA oligomers by E. coli uracil DNA glycosylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

Human thymine DNA glycosylase binds to apurinic sites in DNA but is displaced by human apurinic endonuclease 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

Mutagenic outcome of combined antiviral drug treatment during human immunodeficiency virus type 1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

Crystal structure of human uracil-DNA glycosylase in complex with a protein inhibitor: protein mimicry of DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

Slipping through the door: HIV entry into the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

The HIV-1 Vpr co-activator induces a conformational change in TFIIB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein rR and Bcl-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

NMR structure of the HIV-1 regulatory protein VPR

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

HIV-1 Vpr-chloramphenicol acetyltransferase fusion proteins: sequence requirement for virion incorporation and analysis of antiviral effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

Incorporation of uracil into minus strand DNA affects the specificity of plus strand synthesis initiation during lentiviral reverse transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

Human immunodeficiency virus and AIDS: insights from animal lentiviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

Increased mutation frequency of feline immunodeficiency virus lacking functional deoxyuridine-triphosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

Hypermutation of HIV-1 DNA in the Absence of the Vif Protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403875200

21 January 2018

Identifiers

DOI

10.1074/JBC.M403875200

1 reference

21 September 2017

1 reference